D. Weisdorf

发表

Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse

J. Miller, C. Brunstein, BA Hirsch, 2000, Bone Marrow Transplantation.

Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997

D. Weisdorf, T. Murdych, 2001, Bone Marrow Transplantation.

The spectrum of Malassezia infections in the bone marrow transplant population

D. Weisdorf, V. Morrison, 2000, Bone Marrow Transplantation.

Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies

D. Weisdorf, N. Ramsay, S. Bhatia, 1998, Bone Marrow Transplantation.

Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma

J. Miller, D. Weisdorf, E. Katsanis, 1998, Bone Marrow Transplantation.

Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population.

D. Weisdorf, B. Bostrum, D. Raether, 1989, Pediatric dentistry.

Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood

C. Verfaillie, D. Weisdorf, J. Burroughs, 2003, Bone Marrow Transplantation.

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

J. Wagner, G. Vercellotti, M. Verneris, 2014, Bone Marrow Transplantation.

Recommendations for reporting post-transplant relapse in AML

B. Sandmaier, M. Linden, S. Devine, 2018, Bone Marrow Transplantation.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Sonographic findings in bone marrow transplant patients with symptomatic hepatic venoocclusive disease.

M. Steinbuch, D. Hunter, M. Sharafuddin, 1997, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Acquired factor VII deficiency in hematopoietic stem cell transplant recipients

A. Toor, A. Slungaard, D. Weisdorf, 2002, Bone Marrow Transplantation.

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

D. Weisdorf, N. Ramsay, D. Weisdorf, 1998, Bone Marrow Transplantation.

Infections during mobilizing chemotherapy and following autologous stem cell transplantation

A. Toor, D. Weisdorf, J. V. Burik, 2001, Bone Marrow Transplantation.

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.

G. Schoch, D. Weisdorf, S. Slichter, 1995, Blood.

Alternaria: a sinonasal pathogen of immunocompromised hosts.

V. Morrison, D. Weisdorf, Daniel J. Weisdorf, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Infusion Rate on Amphotericin B-Associated Febrile Reactions

C. Fletcher, J. Cleary, D. Weisdorf, 1988, Drug intelligence & clinical pharmacy.

Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients.

D. Weisdorf, N. Berlinger, D. Weisdorf, 1988, The American journal of medicine.

Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation

M. MacMillan, D. Weisdorf, W. Miller, 2002, Bone Marrow Transplantation.

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival

C. Brunstein, D. Weisdorf, C. Brunstein, 2011, Bone Marrow Transplantation.

Origins of circulating endothelial cells and endothelial outgrowth from blood.

R. Hebbel, D. Weisdorf, A. Solovey, 2000, The Journal of clinical investigation.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation

B. Blazar, D. Weisdorf, J. Nichol, 2000, Bone Marrow Transplantation.

Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility

D. Weisdorf, E. Greeno, S. Ilstrup, 1996, Transfusion.

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study

L. Robison, S. Bhatia, J. Gurney, 2006, Bone Marrow Transplantation.

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

H. Lazarus, C. Ustun, D. Weisdorf, 2013, Bone Marrow Transplantation.

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

J. Wagner, P. Jacobson, T. DeFor, 2009, Bone Marrow Transplantation.

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

M. Horowitz, M. Bishop, Carole B. Miller, 2008, Bone Marrow Transplantation.

Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis

J. Pastor, J. R. Johnson, D. Weisdorf, 1998, Bone Marrow Transplantation.

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission

M. Tanimoto, M. Tomonaga, R. Ohno, 1998, Bone Marrow Transplantation.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Autologous transplant remains the preferred therapy for relapsed APL in CR2

J. Esteve, A. Nagler, M. Mohty, 2016, Bone Marrow Transplantation.

Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy

I. Lewis, D. Weisdorf, D. Weisdorf, 2000, Bone Marrow Transplantation.

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

M. Reding, D. Weisdorf, M. Reding, 2015, Bone Marrow Transplantation.

Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma

M. Arora, J. Miller, D. Weisdorf, 2005, Bone Marrow Transplantation.

Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning

N. Majhail, D. Weisdorf, T. Defor, 2006, Bone Marrow Transplantation.

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

C. Ebens, S. Terezakis, V. Bachanova, 2022, medRxiv.

Blood 2 6 M a R C H 2 0 0 9 I V O L U M E 1 1 3 , N U M B E R 1 3 2873

Mielcarek, Wagner Je, D. Weisdorf, 2022 .

Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.

J. Dunitz, D. Weisdorf, P. Ely, 1991, The American journal of medicine.

Monoclonal antibody AHN-1 inhibits phagocytosis by human neutrophils.

D. Weisdorf, K. Skubitz, P. Peterson, 1985, Blood.

In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts.

B. Bostrom, B. Blazar, J. Kersey, 1989, Blood.

Myeloma Autologous stem cell transplantation in multiple myeloma patients o60 vs X60 years of age

D. Weisdorf, J. Wingard, D. Vesole, 2003 .